Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives

The use of saliva for measuring xenobiotic concentrations has been practiced for a number of years. While the use of saliva has been generally reserved for the analysis of diagnostic and forensic/toxicology samples, attempts have been made to further enhance the value of saliva as an alternate matrix to those of plasma and serum. It is understood that saliva represents a handy tool for therapeutic drug monitoring (TDM) as it offers certain distinctive advantages. This scope of this review encompasses the following: (a) a comprehensive view of saliva as an alternate matrix for either plasma or serum to understand the pharmacokinetic/pharmacodynamic (PK/PD) characteristics; (b) an account of the factors contributing to the observed variability in salivary monitoring; (c) a tabular compilation of diverse case studies of xenobitoics belonging to different therapeutic classes with emphasis on assay methodology and applicable analytical/biopharmaceutical/pharmacokinetic findings; (d) relevant thoughts on assay procedures as they relate to salivary monitoring; and (e) some representative case studies highlighting the new thinking on the use of saliva outside of traditional TDM. Overall, based on the review, saliva represents a valuable TDM tool for a number of xenobiotics. While parent compound and phase I metabolite(s) for many xenobiotics have been generally quantifiable in saliva, phase II metabolites have not generally been detected in saliva. Therefore saliva samples could also be used to answer some specific PK/PD questions during the drug development process, if applicable. However, the development and validation of the assay in saliva needs to be carried out carefully with particular focus on proper sample collection, processing and storage to ensure the stability of the xenobiotics and with the same rigor as applied to plasma, serum and urine matrices.     

职前和在职化学教师“化学平衡”课堂教学解释能力的对比

运用录像分析法,以Hannah Sevian和Lisa Gonsalves设计的教师课堂教学解释能力评价量表为工具,对职前和在职化学教师课堂教学解释能力（以“化学平衡”内容为例）进行测评。研究发现：职前化学教师和在职化学教师的课堂教学解释能力在一般性教学知识（PK）、学科内容知识（CK）、学科教学知识（PCK）等3方面均存在显著差异,即职前化学教师得分由高到低分别为PK、CK、PCK,在职化学教师得分由高到低则分别为PK、PCK、CK;具体差异主要体现在“事实性知识”“将知识运用到不同情境中的能力”“使用心智图像解释”“搭建解释”等方面。     

Study on magnetization reversal of cobalt nanowire arrays by magnetic force microscopy

The magnetic properties of self-assembly cobalt nanowire arrays formed in anodic porous alumina template were investigated by nanosize imaging method and macroscopic magnetic measurement. We have successfully made a wire-by-wire observation of magnetization reversal of a cobalt nanowire array using magnetic force microscopy with a home-made FePt tip. The nanowires in this medium have uniaxial anisotropy with easy axis along the wire due to the large aspect ratio of the wires (30 nm in diameter and 300 nm in length). Considering the nanowires as single-domain structures, we can obtain the average DC demagnetization curve from nanosize images by calculating the number of wires in each magnetized direction, and the results agreed well with the DC demagnetization curve measured by macroscopic measurement. The magnetostatic field between wires was evaluated by a new nanosize imaging method. Macroscopic measurement shows that reversible magnetization occurs in this medium. Nanosize images of the remanent and saturated states prove that the reversible magnetization processes mainly take place inside individual wires and reversed wires induced by magnetostatic field just give a little contribution to the reversible magnetization.     

Development of a validated UPLC–MS/MS method for PK/PD analysis of SYL930 and its two major metabolites in dogs

A sensitive and specific UPLC‐MS/MS method was developed and validated for the simultaneous determination of 2‐amino‐2‐(2‐(4′‐(2‐propyloxazol‐4‐yl)‐[1,1′‐biphenyl]‐4‐yl)ethyl)propane‐1,3‐diol (SYL930), phosphorylated metabolite (SYL930‐P) and hydroxylated metabolite (SYL930‐M) in dog blood using SYL927 and SYL927‐P, analogues of SYL930, as the internal standards. Analytes were extracted with protein precipitation followed by chromatographic separation on a ZorbaxSB‐C₁₈ column (3.5 μm, 2.1 × 100 mm) with a gradient elution of methanol–water containing 0.1% formic acid (v /v). A triple quadrupole tandem mass spectrometer operating in the positive electrospray ionization mode was used to detect SYL930, SYL930‐P, SYL930‐M and IS transitions of 381.2 → 364.2, 461.2 → 334.2, 397.3 → 380.3, 367.1 → 350.4 and 447.5 → 320.2, respectively. The linear calibration curves for SYL930, SYL930‐P and SYL930‐M were 0.5–500, 0.2–100 and 0.5–100 ng/mL, respectively (r ² > 0.99). The intra‐day and inter‐day precisions (RSD, %) of analytes did not exceed 9.16% except for low QCs (≤16.22%), and the accuracy (RE, %) ranged from −14 to 11.4%. The mean recoveries for SYL930, SYL930‐P and SYL930‐M in dog blood were 85.13–107.94, 73.84–80.08 and 85.64–95.44%, respectively. The validated method was successfully applied to pharmacokinetic and PK/PD studies of SYL930 and its two major metabolites in dogs after an oral administration of SYL930.     

The synthesis and cytotoxic evaluation of a series of benzodioxole substituted titanocenes

Using 6‐benzo[1,3]dioxolefulvene ( 1a ), a series of benzodioxole substituted titanocenes was synthesized. The benzyl‐substituted titanocene bis[(benzo[1,3]dioxole)‐5‐methylcyclopentadienyl] titanium (IV) dichloride ( 2a ) was synthesized from the reaction of Super Hydride with 1a . An X‐ray determined crystal structure was obtained for 2a . The ansa‐titanocene {1,2‐di(cyclopentadienyl)‐1,2‐di‐(benzo[1,3]dioxole)‐ethanediyl} titanium(IV) dichloride ( 2b ) was synthesized by reductive dimerisation of 1a with titanium dichloride. The diarylmethyl substituted titanocene bis(di‐(benzo[1,3]dioxole)‐5‐methylcyclopentadienyl) titanium(IV) dichloride ( 2c ) was synthesized by reacting 1a with the para‐lithiated benzodioxole followed by transmetallation with titanium tetrachloride. When titanocenes 2a–c were tested against pig kidney (LLC‐PK) cells inhibitory concentrations (IC₅₀) of 2.8 × 10^?4, 1.6 × 10^?4 and 7.6 × 10^?5 M , respectively, were observed. These values represent improved cytotoxicity against LLC‐PK, when compared with unsubstituted titanocene dichloride, but are not as impressive as values obtained for titanocenes previously synthesized using the above methods. Copyright © 2006 John Wiley & Sons, Ltd.     

Quantitative analysis of clofazimine (Lamprene®), an antileprosy agent,in human dried blood spots using liquid chromatography–tandem mass spectrometry

An LC–MS/MS method was developed and validated for bioanalysis of clofazimine in human dried blood spot (DBS) samples in support of a clinical study on multidrug‐resistant tuberculosis in developing countries. The validated assay dynamic range was from 10.0 to 2000 ng/mL using a 1/8 inch DBS punch. The accuracy and precision of the assay were ±11.0% (bias) and ≤13.5% (CV) for the LLOQs (10.0 ng/mL) and ±15% (bias) and ≤15% (CV) for all other QC levels. The assay was proved to be free from the possible impact owing to spot size and storage temperature (e.g. at 60°C, ≤ − 60°C). The validated assay is well suited for the intended clinical study where conventional pharmacokinetic sample collection is not feasible.     

Morphologies,interfacial interaction and mechanical performance of super-tough nanostructured PK/PA6 blends

Nanostructured polyketone (PK)/polyamide 6 (PA6) blends can be readily prepared via melt blending technologies and exhibit ultra-high toughness when PA6 is present as the nanoscale phase domains. When PA6 content is 30 vol%, the impact strength of the blends increases from 21.4 kJ/m² of pure PK to 103.2 kJ/m². The impact strength of the PK/PA6 blends with a 5:5 composition ratio reaches as high as 113 kJ/m². The strong intermolecular force between PK and PA6 molecular chains enables the PA6 nanophase to cavitate to dissipate a significant amount of impact energy and effectively prevents the crack propagation or even terminates the cracks. The fracture mechanism of the PK/PA6 blends was further examined by the essential work of fracture method which proves that PK/PA6 blends show improved ability to prevent crack propagation. This work may deepen the understanding of polymer blend systems with strong hydrogen bonding interaction.     

The Interplay of Cholesterol and Ligand Binding in hTSPO from Classical Molecular Dynamics Simulations

The translocator protein (TSPO) is a 18kDa transmembrane protein, ubiquitously present in human mitochondria. It is overexpressed in tumor cells and at the sites of neuroinflammation, thus representing an important biomarker, as well as a promising drug target. In mammalian TSPO, there are cholesterol–binding motifs, as well as a binding cavity able to accommodate different chemical compounds. Given the lack of structural information for the human protein, we built a model of human (h) TSPO in the apo state and in complex with PK11195, a molecule routinely used in positron emission tomography (PET) for imaging of neuroinflammatory sites. To better understand the interactions of PK11195 and cholesterol with this pharmacologically relevant protein, we ran molecular dynamics simulations of the apo and holo proteins embedded in a model membrane. We found that: (i) PK11195 stabilizes hTSPO structural fold; (ii) PK11195 might enter in the binding site through transmembrane helices I and II of hTSPO; (iii) PK11195 reduces the frequency of cholesterol binding to the lower, N–terminal part of hTSPO in the inner membrane leaflet, while this impact is less pronounced for the upper, C–terminal part in the outer membrane leaflet, where the ligand binding site is located; (iv) very interestingly, cholesterol most frequently binds simultaneously to the so-called CRAC and CARC regions in TM V in the free form (residues L150–X–Y152–X(3)–R156 and R135–X(2)–Y138–X(2)–L141, respectively). However, when the protein is in complex with PK11195, cholesterol binds equally frequently to the CRAC–resembling motif that we observed in TM I (residues L17–X(2)–F20–X(3)–R24) and to CRAC in TM V. We expect that the CRAC–like motif in TM I will be of interest in future experimental investigations. Thus, our MD simulations provide insight into the structural features of hTSPO and the previously unknown interplay between PK11195 and cholesterol interactions with this pharmacologically relevant protein.     

Determination of partition coefficients using 1H NMR spectroscopy and time domain complete reduction to amplitude‐frequency table (CRAFT) analysis

We have developed a simple, direct and novel method for the determination of partition coefficients and partitioning behavior using ¹H NMR spectroscopy combined with time domain complete reduction to amplitude‐frequency tables (CRAFT). After partitioning into water and 1‐octanol using standard methods, aliquots from each layer are directly analyzed using either proton or selective excitation NMR experiments. Signal amplitudes for each compound from each layer are then extracted directly from the time domain data in an automated fashion and analyzed using the CRAFT software. From these amplitudes, log P and log D_7.4 values can be calculated directly. Phase, baseline and internal standard issues, which can be problematic when Fourier transformed data are used, are unimportant when using time domain data. Furthermore, analytes can contain impurities because only a single resonance is examined and need not be UV active. Using this approach, we examined a variety of pharmaceutically relevant compounds and determined partition coefficients that are in excellent agreement with literature values. To demonstrate the utility of this approach, we also examined salicylic acid in more detail demonstrating an aggregation effect as a function of sample loading and partition coefficient behavior as a function of pH value. This method provides a valuable addition to the medicinal chemist toolbox for determining these important constants. Copyright © 2017 John Wiley & Sons, Ltd.     

水稻叶片Ca~(2 )/CaM依赖性蛋白激酶的纯化和活性测定

通过高速离心、( NH4) 2 SO4沉淀、琼脂糖凝胶过滤和 Ca M- sepharose4B亲和层析 ,从 HPGMR( 5 8S)叶片中初步纯化出 Ca2 / Ca M依赖性蛋白激酶 .纯化的 Ca2 / Ca M依赖性蛋白激酶经 SDS-聚丙烯酰胺凝胶线性梯度电泳 ,亚基分子量约为 5 5× 10 3.在 Ca2 / Ca M依赖性蛋白激酶的标准反应体系中 ,存在过量的 ATP,提取磷酸化反应剩余的 ATP,用叶绿体 Mg2 - ATP酶分解 ATP,最后用复合孔雀绿测定无机磷 ,从而来计算 Ca2 / Ca M依赖性蛋白激酶的活性 .实验结果表明 ,该酶活性是依赖 Ca2 和 Ca M的 ,并且 EGTA和 TFP对酶活性有明显的抑制作用